Topics: R. 221 RoP
-
CoA, October 13, 2026, order on application for leave to appeal, UPC-CoA-88/2026 and UPC-CoA-89/2026
No leave to appeal re. application for re-establishement of rights: Headnote: An application for leave to appeal pursuant to R. 157 RoP in conjunction with R. 221 RoP is inadmissible insofar as it concerns a rejection of the application for re-establishment of rights. According to R. 320.7 RoP, there shall be no right to appeal…
1 min Reading time→ -
Court of Appeal, 3 July 2026, Order, UPC_CoA_302/2025 & UPC_CoA_305/2025
An application for a cost decision must always be filed with the CFI even if the costs arise exclusively from appeal proceedings: Proceedings for cost decision is a distinct, separate procedure under Rules 150 et seq. RoP, always commencing before the Court of First Instance (CFI). Otherwise, no appeal against cost decisions would be possible…
3 min Reading time→ -
Contact us personally!
Tips and advice directly from our Unitary Patents professionals.
-
Court of Appeal, June 29, 2026, Denies Leave to Appeal Cost Decision
Appeals of cost decisions are subject to a limited ‘marginal review’ for reasonableness and proportionality, not a full re-assessment (R. 221 RoP, R. 156.2 RoP): This limited review is justified because the first-instance judge-rapporteur, who decides on costs in writing under R. 156.2 RoP, has managed the case throughout and is best positioned to assess…
4 min Reading time→ -
Court of Appeal, December 24, 2025, Order concerning an application for leave to appeal against a cost decision, UPC-COA-0000911/2025
Appellate review of cost decisions is limited to a marginal review (Art. 69 UPCA, R. 221 RoP): The Court of Appeal only intervenes if awarded costs are beyond “reasonable and proportionate” or deviate from principles inherent in Art. 69 (1) UPCA and R. 150 et seqq. The Court of Appeal recognizes that the first-instance judge-rapporteur…
3 min Reading time→
Stay in the loop
Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.